A dietary therapy for pediatric epilepsy known as the ketogenic diet has seen a revival in its clinical use during the past decade. Although the underlying mechanism of the diet remains unknown, modern scientific approaches, such as the genetic disruption of glucose metabolism, are allowing for more detailed questions to be addressed. Recent work indicates that several mechanisms may exist for the ketogenic diet, including disruption of glutamatergic synaptic transmission, inhibition of glycolysis, and activation of ATP-sensitive potassium channels. Here, we describe on-going work in these areas that is providing a better understanding of metabolic influences on brain excitability and epilepsy.
The ketogenic diet treatment for epilepsy Trends in neuroscience come and go. In the 1920s' world of clinical neurology, momentum gathered behind the idea of treating epileptic seizures not with the few and rather inadequate medications available at the time, but by a radical change in diet: elimination of all but a tiny amount of ingested carbohydrate and substitution mostly by dietary fat, a so-called 'ketogenic diet' (Box 1). Then, despite many reports of the effectiveness of this diet in reducing seizures in patients with epilepsy, the diet was quick to fade from the clinical arsenal once the first really effective modern anticonvulsant drug, diphenylhydantoin, was introduced during the late 1930s.
Decades later, and with dozens of new anticonvulsant drugs, approximately one-third of patients with epilepsy still fail to achieve significant relief from seizures with drug treatment [1] . Clinical interest in the ketogenic diet was renewed during the 1990s, specifically as a treatment for children with drug-resistant seizures. Its efficacy has been supported in retrospective and prospective studies, as well as in a recent randomized trial [2], and many major centers now offer dietary therapy for epilepsy. However, its utilization in patients with epilepsy remains low for a variety of reasons, including tolerability, compliance with the strict diet, management, training in diet administration, and a general reluctance on the part of neurologists to use dietary therapy.
Still, the diet often succeeds in control of seizures when drugs fail, indicating that the metabolic changes produced by the diet tap into anticonvulsant mechanisms that are not targeted by existing medications. Neurobiologists' interest in dissecting and, ultimately, reverse engineering the nature of these mechanisms is on the rise, and here we review the latest insights from this work.
How can altered diet, and the ensuing changes in brain metabolism, affect brain excitability? Neuronal excitability is intertwined with energy metabolism in multiple ways. At the most basic level, maintenance of neuronal function incurs a substantial energy demand, and this demand must be met by active cellular metabolism (Box 2). It is also known that certain specialized neurons and neuroendocrine cells are specially tuned to sense metabolic changes, to regulate hormonal secretion, energy management, and feeding behavior. However, in addition to these obvious links between excitability and metabolism, many neurons whose primary function is not the sensing of metabolism can also alter their excitability in response to metabolic changes.
Metabolic changes associated with the ketogenic diet
The classic ketogenic diet consists of a 4:1 ratio of fats to proteins and carbohydrates [3] . This drastic decrease in carbohydrates reduces the amount of glucose utilization. Instead, fatty acids are used by the liver to produce the ketone bodies, beta-hydroxybutyrate (BHB) and acetoacetate, which fuel cellular metabolism in lieu of glucose. Much of the energy production of the body goes into fueling neurons, which have a high rate of energy expenditure (Box 2). On the ketogenic diet, ketone bodies replace glucose as the major fuel source for the brain [4] .
Do ketone bodies reduce neuronal excitability?
The two major areas of focus in research on the ketogenic diet have been the ketone bodies themselves and the metabolic changes associated with decreased glucose oxidation. Early clinical studies of dietary treatment of epilepsy attributed seizure protection to ketosis, and injection of ketone bodies has been described to be anticonvulsant [5] [6] [7] . In animal models, the level of ketosis has not correlated well with the degree of efficacy of the ketogenic diet [8] [9] [10] [11] . However, in humans, there is still evidence for the importance of elevated blood ketone bodies [12, 13] and brain ketone body levels may end up correlating with seizure protection. Several recent studies have directly examined the role of ketone bodies on neuronal excitability.
